Skip to main content

Table 1 Baseline characteristics and demographics of patients with acute CSC

From: Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy

 

STMP Group

Half-dose PDT Group

P value

Variables

(n = 18)

(n = 21)

 

Age, mean ± SD, (years)

37.22 ± 7.83

38.76 ± 8.08

0.582

Gender, (n)

 Male

13

14

 

 Female

5

7

0.742

Duration of symptoms,

 mean ± SD, (days)

25.06 ± 16.09

21.33 ± 15.63

0.359

Baseline BCVA, mean ± SD,

  (ETDRS)

63.67 ± 9.79

62.81 ± 8.52

0.772

Baseline CFT, mean ± SD,

  (μm)

427.28 ± 52.23

423.38 ± 47.39

0.808

Baseline retinal

 sensitivity, mean ± SD, (dB)

12.29 ± 1.88

12.61 ± 1.95

0.601

 Presence of macular PED, (n)

3(16.7%)

5(23.8%)

0.702

Location of leakage site, (n)

 Subfoveal

2

4

 

 Juxtafoveal

14

15

 

 Extrafoveal

2

2

0.789

Number of leakage point, (n)

 1

15

16

 

 2

3

4

 

 3

0

1

0.622

  1. CSC central serous chorioretinopathy, STMP subthreshold micropulse, PDT photodynamic therapy, SD standard deviation, BCVA best-corrected visual acuity, ETDRS Early Treatment Diabetic Retinopathy Study, CFT central foveal thickness, PED pigment epithelial detachment